These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 7908436)

  • 1. Abecarnil shows reduced tolerance development and dependence potential in comparison to diazepam: animal studies.
    Löscher W
    Psychopharmacol Ser; 1993; 11():96-112. PubMed ID: 7908436
    [No Abstract]   [Full Text] [Related]  

  • 2. Abecarnil, a beta-carboline derivative, does not exhibit anticonvulsant tolerance or withdrawal effects in mice.
    Natolino F; Zanotti A; Contarino A; Lipartiti M; Giusti P
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Nov; 354(5):612-7. PubMed ID: 8938660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Withdrawal precipitation by benzodiazepine receptor antagonists in dogs chronically treated with diazepam or the novel anxiolytic and anticonvulsant beta-carboline abecarnil.
    Löscher W; Hönack D
    Naunyn Schmiedebergs Arch Pharmacol; 1992 Apr; 345(4):452-60. PubMed ID: 1352384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Behavioral pharmacology of abecarnil in baboons: reduced dependence and abuse potential.
    Sannerud CA; Ator NA; Griffiths RR
    Psychopharmacol Ser; 1993; 11():113-20. PubMed ID: 7908430
    [No Abstract]   [Full Text] [Related]  

  • 5. "Anxiolytic" action of diazepam and abecarnil in a modified open field test.
    Rex A; Stephens DN; Fink H
    Pharmacol Biochem Behav; 1996 Apr; 53(4):1005-11. PubMed ID: 8801571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term studies on anticonvulsant tolerance and withdrawal characteristics of benzodiazepine receptor ligands in different seizure models in mice. I. Comparison of diazepam, clonazepam, clobazam and abecarnil.
    Löscher W; Rundfeldt C; Hönack D; Ebert U
    J Pharmacol Exp Ther; 1996 Nov; 279(2):561-72. PubMed ID: 8930158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic pharmacological activities of the novel anxiolytic beta-carboline abecarnil in rats.
    Ozawa M; Sugimachi K; Nakada-Kometani Y; Akai T; Yamaguchi M
    J Pharmacol Exp Ther; 1994 May; 269(2):457-62. PubMed ID: 7910208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term treatment with abecarnil fails to induce tolerance in mice.
    Serra M; Ghiani CA; Motzo C; Porceddu ML; Biggio G
    Eur J Pharmacol; 1994 Jun; 259(1):1-6. PubMed ID: 7957586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics, anticonvulsant efficacy and adverse effects of the beta-carboline abecarnil, a novel ligand for benzodiazepine receptors, after acute and chronic administration in dogs.
    Löscher W; Hönack D; Scherkl R; Hashem A; Frey HH
    J Pharmacol Exp Ther; 1990 Nov; 255(2):541-8. PubMed ID: 1978730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antagonism of isoniazid-induced convulsions by abecarnil in mice tolerant to diazepam.
    Serra M; Ghiani CA; Motzo C; Porceddu ML; Biggio G
    Pharmacol Biochem Behav; 1995 Oct; 52(2):249-54. PubMed ID: 8577786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repeated treatment with alpidem, a new anxiolytic, does not induce tolerance or physical dependence.
    Perrault G; Morel E; Sanger DJ; Zivkovic B
    Neuropharmacology; 1993 Sep; 32(9):855-63. PubMed ID: 7901790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physical dependence on diazepam in the dog: precipitation of different abstinence syndromes by the benzodiazepine receptor antagonists Ro 15-1788 and ZK 93426.
    Löscher W; Hönack D; Fassbender CP
    Br J Pharmacol; 1989 Jul; 97(3):843-52. PubMed ID: 2569347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of abecarnil, bretazenil, and RO 19-8022 with diazepam-sensitive and -insensitive benzodiazepine sites in the rat cerebellum and cerebral cortex.
    Mehta AK; Shank RP
    Life Sci; 1995; 57(24):2215-22. PubMed ID: 7475974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential effects of abecarnil on basal release of acetylcholine and dopamine in the rat brain.
    Imperato A; Dazzi L; Serra M; Gessa GL; Biggio G
    Eur J Pharmacol; 1994 Aug; 261(1-2):205-8. PubMed ID: 8001645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abecarnil, a metabolically stable, anxioselective beta-carboline acting at benzodiazepine receptors.
    Stephens DN; Schneider HH; Kehr W; Andrews JS; Rettig KJ; Turski L; Schmiechen R; Turner JD; Jensen LH; Petersen EN
    J Pharmacol Exp Ther; 1990 Apr; 253(1):334-43. PubMed ID: 1970361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anticonvulsant action of the beta-carboline abecarnil: studies in rodents and baboon, Papio papio.
    Turski L; Stephens DN; Jensen LH; Petersen EN; Meldrum BS; Patel S; Hansen JB; Löscher W; Schneider HH; Schmiechen R
    J Pharmacol Exp Ther; 1990 Apr; 253(1):344-52. PubMed ID: 1970362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term treatment with abecarnil does not induce diazepam-like dependence in mice.
    Steppuhn KG; Schneider HH; Turski L; Stephens DN
    J Pharmacol Exp Ther; 1993 Mar; 264(3):1395-400. PubMed ID: 8095551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of basal and stress-induced release of acetylcholine and dopamine in rat brain by abecarnil and imidazenil, two anxioselective gamma-aminobutyric acidA receptor modulators.
    Dazzi L; Motzo C; Imperato A; Serra M; Gessa GL; Biggio G
    J Pharmacol Exp Ther; 1995 Apr; 273(1):241-7. PubMed ID: 7714771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study of the modulatory activity of BZ (omega) receptor ligands on defensive behaviors in mice: evaluation of the importance of intrinsic efficacy and receptor subtype selectivity.
    Griebel G; Perrault G; Sanger DJ
    Prog Neuropsychopharmacol Biol Psychiatry; 1999 Jan; 23(1):81-98. PubMed ID: 10368858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abecarnil enhances recovery from diazepam tolerance.
    Zanotti A; Natolino F; Contarino A; Lipartiti M; Giusti P
    Neuropharmacology; 1999 Sep; 38(9):1281-8. PubMed ID: 10471081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.